Infection Control – Full Control of the Decontamination Processes

Four smiling medical surgeons in hospital scrubs

Increased demands on faster instruments turnaround can now be satisfied with Terragene®’s Rapid Fluorescence Readout Systems. New Super Rapid, Rapid Self-contained Biological Indicators and Hygiene Monitoring Pen System allow to control and quantify the decontamination process. This system grants accurate, reliable information that are registered in the Traceability Software.

 Infection prevention for the Healthcare

Sychem Incubators

 rapid readout incubators

Sychem Hygiene Monitoring

protein residue tests

Sychem BIs

 biological indicators


  • Easy to use. Results are obtained in record time allowing faster release of sterilized loads.
  • Fluorescence technology provides the needed information when there is still time to act.
  • Fluorescence readout of all Rapid, Super Rapid SCBIs and Hygiene Monitoring Systems is carried out in just 1 incubator, the Bionova® IC10/20FRLCD.
  • Final readout and related information will automatically flow into your system through the Bionova ® Traceability Software

Compliance with the latest standards

The HTM 01-01 (update July 2016)  offers guidance on the prevention and control of infections. All healthcare providers are required to demonstrate the precence of decontamination policies, to establish that essential quality requirements and plans are in place for progression to best practice.
The purpose of the HTM01-01 is to help health organisations to develop policies regarding the management, use, and decontamination of reusable medical devices at controlled costs using risk control. Overall, the HTM is designed to reflect the need to continuously improve patient safety and clinical effectiveness.


With the implementation of the HTM01-01, all acute providers will have to demonstrate that they operate safely with respect to its decontamination services, defining how they achieve risk control and what plan is in place to work towards Best Practice. Therefore, Best Practice will be achieved by: covering procedures that aim to further minimise risks to patients; delivering better patient outcomes; promoting and encouraging innovation and choice, and achieving cost efficiencies. All new procedures that will contribute to improved clinical outcomes for the instrument management should therefore be taken into consideration.